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Depressive symptoms in patients with rheumatoid 
arthritis (RA) frequently coincide with reports of greater 
pain (1-3) and functional disability (4-6). Although the 
link between depression and RA symptoms has been 
widely explored, our understanding remains limited 
due to the kinds of data available and the research ques-
tions that are typically asked. Most studies have exam-
ined symptoms of depression using depression ques-
tionnaires rather than structured diagnostic interviews, 
and have focused exclusively on the patient’s current 
psychological status. 
The study described herein departs from most others 
by focusing on the diagnosis of major depression, and 
by considering how both previous and current depres-
sion are related to reports of pain, fatigue, and disability. 
The clinical significance of our findings lies primarily in 
the practice implications. Until recently, rheumatolo-
gists and other physicians have paid scant attention to 
depression and its relationship to RA symptoms. Al-
though there is now greater awareness of depression 
and its treatment, the focus of this awareness has been 
on current depression. Yet, even the most careful assess-
ment of current depression will not reveal a history of 
depression, which has a reported prevalence of 20% in 
community studies (7). 
The relationship between RA symptoms and emo-
tional distress has attracted the attention of both clini-
cians and researchers. Published studies have taken 
a variety of perspectives on this relationship, includ-
ing investigation of whether pain is a predictor of de-
pression (1-3) or whether depression influences pain (8), 
and identification of factors mediating the pain-depres-
sion relationship (9-11). Although the number of studies 
linking depression and RA symptoms is growing, inves-
tigations have been limited primarily to cross-sectional 
studies that use depression questionnaires and examine 
concurrent associations. Compared with the large num-
ber of studies that have utilized questionnaires such as 
the Center for Epidemiological Studies Depression Scale 
(CES-D) (12) or the Beck Depression Inventory (13), very 
few published studies have examined the link with the 
diagnosis of major depression (2). Questionnaire indi-
cators of depression have shown only modest concor-
dance with the diagnosis of major depression (14, 15) 
and have a limited ability to discriminate between de-
pression and anxiety (16). Unlike the diagnosis of ma-
jor depression, which requires both necessary and suf-
ficient symptoms, depression questionnaires reflect the 
presence of psychological distress or dysphoria, and not 
necessarily a depressive disorder (17). Thus, our knowl-
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Abstract
Objective. To determine whether a previous episode of major depression leaves a “scar” that places previously depressed patients 
with rheumatoid arthritis (RA) at risk for experiencing high levels of pain, fatigue, and disability. 
Methods. A cohort of 203 patients with RA was randomly selected from a national panel and interviewed by phone about pain, fa-
tigue, depressive symptoms, disability, and history of major depression. 
Results. Excluding patients who met the criteria for current major depression, patients with both a history of depression and many 
depressive symptoms at the time of the interview (dysphoria) reported more pain than those without current dysphoria, irre-
spective of whether they had a history of depression. Dysphoria alone was not reliably related to pain reports. 
Conclusion. An episode of major depression, even if it occurs prior to the onset of RA, leaves patients at risk for higher levels of 
pain when depressive symptoms persist, even years after the depressive episode.
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edge of the relationship between depressive disorder 
and the common symptoms of RA, such as pain, fatigue, 
and functional disability, derives from only a handful of 
studies (2). 
Whereas questionnaire-based investigations of de-
pression and RA have focused on global distress, and 
the few interview-based studies have examined current 
depression, a growing body of evidence has converged 
on the notion that major depression may leave a psy-
chological “scar,” as first suggested by Lewinsohn and 
colleagues (18), or may precipitate residual dysfunction 
even after the formerly depressed individual no longer 
meets the criteria for a depressive disorder. This “scar” 
makes the formally depressed person vulnerable to re-
current depression and to interpersonal, occupational, 
and health deficits between depressive episodes. At 
this point, it is not clear whether these deficits are re-
sidua of the prior depression, a constellation of traits 
that remain stable between and within episodes, or a 
risk factor for recurrence (19). Moreover, it is not clear 
whether such a “scar” remains latent until triggered, 
or “primed,” by a particular emotional state. There is 
some evidence that dysphoric mood may be the prim-
ing condition (20-22). Despite growing evidence from 
the general population (18) and from a recent study of 
fibromyalgia patients (23) that major depression may 
leave a “scar,” this idea has not been investigated in an 
RA patient population. 
This study examined the hypothesis that an episode 
of major depression leaves a “scar,” such that formerly 
depressed patients with RA, even years after the oc-
currence of depression, are at increased risk for expe-
riencing high levels of pain, fatigue, and disability. We 
also tested the priming hypothesis (20-21), i.e., that the 
“scar” associated with a history of depression will only 
be evident in the presence of a current dysphoric mood. 
Thus, RA patients with a history of depression will re-
port higher levels of pain, fatigue, and disability com-
pared with patients with no such history, but only when 
experiencing a dysphoric mood. 
Patients and Methods 
Study design. The National Rheumatoid Arthritis Study 
is a prospective panel study that completed its tenth and fi-
nal year in 1997. The data for the present analysis were ob-
tained in the sixth year of the study, during an annual tele-
phone interview. 
Patient recruitment. Patients were recruited using a 2-
stage sampling strategy. First, a random sample of board-
certified rheumatologists was selected from the membership 
database of the American College of Rheumatology (ACR). 
In 1987, 2,400 members of the ACR were listed as fellows, 
which is an indication of board certification. To obtain a rep-
resentative sample of 55-60 physicians, 116 physician names 
were selected using computer-generated random numbers. 
After mail and telephone contact, 56 physicians agreed to 
participate (a 48% response rate). 
In the second stage, patients with a diagnosis of classic 
or definite RA according to the ACR (formerly, the Ameri-
can Rheumatism Association) 1958 criteria (24) were offered 
the opportunity to learn more about the study through par-
ticipating physicians’ practices. One thousand forty-nine pa-
tients completed a response card at the physician’s practice 
setting, and the office staff returned the cards to the coor-
dinators of the study at the University of Connecticut. The 
number of patients from each practice ranged from 3 to 43, 
with a mean of 20 patients from each practice. 
Patients who returned cards were contacted by phone and 
asked if they would be willing to be interviewed and have 
their physicians submit to the investigators medical informa-
tion from their charts. In 1987-1988, 988 (94%) of those ini-
tially expressing interest agreed to be interviewed, of whom 
921 (93%) returned the written consent form by mail, qual-
ifying them to participate in telephone interviews. Thus, 
the response rate was 88% (921 of 1,049). In the sixth year 
of the study (1993), 605 participants (66%) remained in the 
study. In an attempt to assess whether people with high lev-
els of depressive symptoms were more likely to drop out of 
the study, thus biasing the sample toward less depression, 
we examined CES-D scores over the 6 years of the study. We 
found that while people scoring higher than the cutoff value 
of 16 (denoting possible clinical depression on the CES-D) 
were significantly more likely to drop out than those scor-
ing below 16 in 3 of the 6 years, in every year, the majority 
of participants with high CES-D scores remained in the sam-
ple (between 78% and 91 % across the 6 years). In each of the 
6 years, nearly the same percentage of study participants (30-
36%) scored above 16 on the CES-D. 
Among the 605 patients eligible to be interviewed in 1993, 
227 (45 men, 182 women) were chosen at random to be ques-
tioned using the depression section of the Diagnostic Inter-
view Survey III-A (DIS III-A) (25). This DIS subgroup was 
not significantly different in terms of any demographic, dis-
ease, or illness variable, including pain, fatigue, functional 
ability, and depressive symptoms, compared with the 378 
patients who remained in the total sample by the sixth year 
of study. Among the 227 patients selected, 203 completed the 
DIS interview. 
Patient assessment. The telephone interview consisted of 
>100 questions related to demographics, self-reported illness 
symptoms, functional ability, and depressive symptoms. In 
addition, the DIS III-A (25) interview included structured 
questions that identified both current and lifetime diagnoses 
of major depression. 
Telephone interview. Demographic variables obtained in-
cluded age, sex, education, family income, marital status, 
and working status. RA illness symptoms were measured by 
self- reported pain and fatigue. Pain was measured by asking 
patients, “On a scale of 0 to 100, with 0 being no pain and 100 
being the most pain possible, how much arthritis pain did 
you feel in the past week?” Fatigue over the past week was 
measured on the same scale. Comparable scales have been 
applied successfully in other studies of RA (26). 
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Functional ability was measured using the Stanford 
Health Assessment Questionnaire (HAQ) (27). The HAQ has 
20 items that measure functional ability in 8 domains: dress-
ing, grooming, arising, eating, walking, hygiene, reach, and 
activities ( = 0.93). Scores on the HAQ range from 0 to 3. 
This scale has been shown to have good reliability and valid-
ity in RA studies (27). 
To assess dysphoric mood, the CES-D (12) was used. The 
CES-D is a 20-item questionnaire that reflects various aspects 
of depression, including depressed mood, feelings of guilt 
and worthlessness, loss of appetite, and sleep disturbance ( 
= 0.70). It yields a single summary score that ranges from 0 
to 60. Good reliability and validity have been reported (12). 
Diagnosis of major depression. The DIS III-A (25) was used 
to confirm diagnoses of both current and lifetime depres-
sion according to the criteria of the Diagnostic and Statistical 
Manual of Mental Disorders, Third Edition, Revised (DSM-
III-R) (7). The DIS III-A represents a minor modification of 
the DIS III (25). The validity of the DIS III has been demon-
strated previously (28), and Wells and colleagues (29) have 
found that phone and face-to-face administrations produce 
comparable results. One interviewer, trained by an expe-
rienced DIS editor, conducted all 203 interviews. All inter-
views were edited by one of the authors (JF), and difficult 
cases were reviewed by a clinical psychologist (HT). The in-
terviewer decision as to whether a symptom was a plausi-
ble psychiatric symptom was reversed by the clinical psy-
chologist in 5 of the interviews that were reviewed. None 
of the reversals resulted in a change in diagnosis different 
from that arrived at by the interviewer. Twenty-eight inter-
views were audited for accuracy by the study director (JF) 
and found to have better than 99% agreement, with a range 
of 95% to 100%. 
The DSM-III-R (7) criteria that were required for partici-
pants to qualify for a diagnosis of lifetime major depression 
included the presence of depressed mood, or loss of inter-
est and pleasure in things that the individual usually cared 
about or enjoyed, lasting every day or nearly every day for 
22 weeks at sometime in the past, while at the same time, ex-
periencing at least 4 of 8 symptoms, specifically problems 
with appetite, sleep, fatigue, energy, interest, self-worth, 
cognition, or suicidal ideas. In addition, the depressive ep-
isode could not be due to injury, illness, medication, or al-
cohol. Diagnosis of current major depression required the 
presence of all of the above-described criteria within 3 weeks 
of the interview. Those who met all the criteria were classi-
fied as having definite major depression (lifetime and/or 
current). Those who met all the criteria but reported symp-
toms lasting <2 weeks were classified as having subthresh-
old depression. Those who attributed ≥1 symptom to an ill-
ness, injury, or drug or alcohol use were classified as having 
either definite or subthreshold major depression with medi-
cal attribution. 
Because we used a short window of only the past 2 
weeks as the time frame for current depression, we created 
the category of subthreshold to capture those cases in which 
all criteria were met, but which lasted short of 2 weeks. Us-
ing the DIS III-A, no symptom was counted toward a de-
pression diagnosis if it was attributed, by either the respon-
dent or a clinician, to a physical illness, injury, medication, 
or alcohol. 
We followed these strict exclusion criteria (30); however, 
instead of discarding the cases, we created the special catego-
ries of definite or subthreshold major depression with medi-
cal attribution. Doing so allowed us to determine the number 
of respondents with RA who appeared to have had definite 
or subthreshold depression, but who attributed some or all 
of their symptoms to something else (usually their RA). 
Current therapy. Current use of medications was deter-
mined by self-report. Patients were read a list of frequently 
prescribed arthritis medications and were asked whether 
these particular medications were part of their current treat-
ment regimen. 
Statistical analysis. After examining the univariate distri-
bution of the data, we assessed the relationship among life-
time depression diagnoses, current RA symptom reports, 
and dysphoric mood, using one-way analysis of variance 
(ANOVA) and logistic regression. This was done to explore 
whether a lifetime diagnosis carried a future risk for higher 
levels of symptoms, irrespective of a priming condition. We 
then used ANOVA to assess the relationship between life-
time diagnoses combined with current levels of dysphoria 
and current reports of fatigue and disability, to test the hy-
pothesis that a priming condition is necessary to reveal the 
risk associated with a lifetime diagnosis. In the statistical 
analyses, we combined all definite cases of major depression 
with definite cases of depression with medical attribution, 
and we combined all subthreshold cases with all subthresh-
old cases with medical attribution. A consulting liaison psy-
chiatrist, using an etiologic approach (31), reviewed a sub-
sample of cases of major depression with medical attribution 
and deemed the majority of them to be actual cases of major 
depression, thus justifying the combining of cases. 
Results 
Description of the sample. Participants were pri-
marily married (67%), middle-aged (mean ± SD 55.5 ± 
10 years) women (78%) who were relatively well-edu-
cated (mean ± SD 13.6 ± 3 years of education completed) 
and from homes with middle-class incomes (median 
$35,000). Forty-six percent of the patients were working 
outside the home for pay. This profile is not unlike that 
in other large studies of RA patients. 
The group had an average duration of RA of 17 years 
(SD 8). The mean score on the CES-D depressive-symp-
tom scale was 11 (SD 10), which is above the general pop-
ulation mean of 9.25 but below the score of 16 that is of-
ten thought to indicate possible clinical depression (12). 
Participants reported moderate levels of fatigue (mean ± 
SD score 50 ± 27), pain (44 ± 29), and functional disabil-
ity (0.69 ± 0.55), which has been seen in other studies as 
well. Correlations among these 4 health status indicators 
ranged from 0.48 (between functional ability and depres-
sive symptoms) to 0.73 (between pain and fatigue). 
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Table 1 shows that only 3.4% of the subset of 203 
participants met the full DSM-III-R (7) criteria for cur-
rent definite major depression, with another 4.5% meet-
ing the criteria for definite major depression with med-
ical attribution, subthreshold major depression, or 
subthreshold major depression with medical attribu-
tion. These proportions were very similar to those found 
in community studies (7). Many more participants met 
the criteria for a lifetime diagnosis. Twenty-eight per-
cent met the full criteria for lifetime depression, and an-
other 26.6% met the criteria for definite depression with 
medical attribution, subthreshold depression, and sub-
threshold depression with medical attribution. The pro-
portions meeting the full criteria were very similar to the 
high end of the range for women meeting the full crite-
ria in community studies (7). Overall, more than half of 
the participants had an episode of definite depression, 
subthreshold depression, or depression with medical at-
tribution at some time in their life. There were no signif-
icant differences between the groups in terms of age, in-
come, education, or sex. 
The frequency of current major depression was not 
equally distributed across the various categories of life-
time depression. Individuals with a history of depression 
who met the criteria for definite major depression were 
more likely to meet the criteria for current definite or sub-
threshold depression (χ2 = 38.58, P < 0.001). Of the 56 pa-
tients with a past episode of major depression, 15 (27%) 
qualified for a current depression diagnosis, whereas 
among those without a history of depression, only 1 met 
the criteria for current depression. There were no current 
cases of major depression among patients who reported 
a lifetime diagnosis of definite depression with medical 
attribution, subthreshold depression, or subthreshold de-
pression with medical attribution. 
To explore whether patients with a lifetime diagno-
sis were at risk for elevated levels of distress even years 
later (mean ± SD years since episode of depression 14.4 
± 10.3), we compared the difference in dysphoric mood, 
measured with the CES-D, across diagnostic catego-
ries with and without the inclusion of current definite 
cases of depression. It is noteworthy that 55% of those 
reporting a past episode of depression reported expe-
riencing the depression prior to the onset of their RA. 
When current definite cases were included, we found a 
significant difference in CES-D scores (F[2,203] = 6.6, P 
< 0.002). Those with a lifetime definite diagnosis of de-
pression obtained a mean CES-D score of 13.60 (SD 10.2) 
compared with 8.4 (SD 9.4) for those with no history of 
depression and 8.6 (SD 9.7) for those with a subthresh-
old depression. When cases of current depression were 
removed from the analysis, no significant differences in 
dysphoria emerged across the lifetime depression cate-
gories (F[2,184] = 1.59, P > 0.20). Thus, there was no sig-
nificant difference in the intensity of depressive symp-
toms for those with and those without a history of 
definite major depression or subthreshold depression. 
Logistic regression revealed that neither patients with a 
history of subthreshold depression (B = –0.12, P = 0.83) 
nor those with a history of definite depression (B = 0.58, 
P = 0.13) were more likely to report current dysphoric 
symptoms above a CES-D score of 16, which is the cut-
off value that, according to Radloff (12), may indicate a 
case of depression. 
We hypothesized that the levels of pain, fatigue, and 
functional ability would differ across categories of life-
time depression. Table 2 summarizes the ANOVA re-
sults, which revealed that pain and fatigue did not vary 
across lifetime diagnostic categories. However, func-
tional disability did vary across diagnoses (F[2,184] = 
3.6, P < 0.03). Although no 2 groups were significantly 
different at the 0.05 level, those with a definite lifetime 
diagnosis reported more functional disability (mean 
0.80) compared with those with a subthreshold lifetime 
diagnosis (mean 0.51) and those with no lifetime diag-
nosis (mean 0.61). 
Table 1. Distribution of diagnoses of current and lifetime ma-
jor depression* 
Diagnosis                                             Frequency             Percent 
Current   
MD definite  7  3.4 
MD definite/medical  4 2.0
MD subthreshold  2  1.0 
MD subthreshold/medical  3  1.5 
No current diagnosis  187 92.0
Lifetime    
MD definite  57  28.1 
MD definite/medical  28 13.8
MD subthreshold  11  5.4 
MD subthreshold/medical  15  7.4 
No lifetime diagnosis  92  45.3 
* Total of 203 patients evaluated. MD = major depression. 
Table 2. Pain, fatigue, and functional ability by lifetime diag-
noses, excluding currently diagnosed cases.
                                          Mean       Mean      Mean
                                           pain       fatigue  disability 
Lifetime diagnosis        score  score  score     N 
Definite MD*  41.96  51.7  0.80  67 
Subthreshold MD  39.4  46.7  0.51  26 
No lifetime diagnosis  41.7 44.1 0.61 91
Total  41.5  47.3  0.66  184 
P  0.922  0.211  0.03  -
* MD = major depression. 
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According to the priming hypothesis, RA patients 
with a history of depression will report higher levels of 
pain, fatigue, and disability than patients without a de-
pression history only in the presence of a currently dys-
phoric mood. To test this priming hypothesis. ANOVA 
was used to compare the mean levels of pain and fatigue 
across categories based on lifetime diagnoses and cur-
rent high levels (CES-D score ≥16) or low levels (CES-
D score <16) of dysphoria. The 4 cases of subthreshold 
depression with high dysphoria were excluded from the 
analysis. Table 3 shows that patients with a lifetime his-
tory of definite major depression who were currently 
experiencing high levels of dysphoria reported the high-
est levels of pain, fatigue, and disability. Those with no 
lifetime diagnosis, but who reported high levels of cur-
rent dysphoria, reported the next highest levels of all 3 
health status indicators. Most critical to the priming hy-
pothesis, those who had an episode of definite major 
depression at some time in their life and who reported 
high levels of current dysphoria, but did not currently 
qualify for even a subthreshold DSM-III-R diagnosis, 
reported significantly more pain than those who had a 
similar past episode of depression but reported low lev-
els of current dysphoria. Although patients with high 
levels of current dysphoria in the absence of a prior de-
pression also reported high levels of pain, the intensity 
of their pain was not significantly different from any 
other group. Thus, in relation to self-reported pain, the 
group that stands out as different had both a history of 
depression and high current dysphoria. 
In contrast to the relationship with pain, both groups 
with high levels of current dysphoria irrespective of a 
history of major depression reported more fatigue and 
functional disability than did their low-dysphoric coun-
terparts. Interestingly, those with a history of definite 
depression but low current dysphoria reported levels of 
all 3 health status indicators in the same range as those 
with no depression history of any kind and low levels of 
current dysphoria. 
Finally, because pain, fatigue, and functional disabil-
ity are all interrelated, and because arthritis medications 
may explain differences in pain reports across groups, 
we examined pain reports across the same lifetime cate-
gories in Table 3, controlling for fatigue, functional dis-
ability, current methotrexate therapy, and current pred-
nisone therapy. Pain reports differed significantly across 
the 5 lifetime diagnostic categories (F[4,180] = 2.83, P < 
0.02) after controlling for fatigue and disability. Planned 
contrasts showed that patients with high dysphoria but 
without a history of depression did not report higher 
levels of pain than those with a history of depression 
but low levels of current dysphoria. Only patients with 
past definite major depression and high current dyspho-
ria reported more pain than those with a history of defi-
nite depression, but low current dysphoria. 
Discussion 
The connection between depression and the illness 
experience of patients with RA has attracted consider-
able attention from researchers and clinicians. However, 
scant attention has been paid to the history of affective 
disorder and the possibility that the past could shape 
the future illness experience. The present study departs 
from the nearly exclusive focus on the connection be-
tween current emotional distress and current illness, to 
suggest that a patient’s affective history may influence 
his or her future illness experience. Thus, this study is 
unique in the arthritis depression literature, since it in-
cludes depressive diagnoses, both past and current, 
Table 3. Analysis of variance results of pain, fatigue, and disability by lifetime diagnoses and current dysphoria (high/low)
                                                                                 Mean                              Mean                                Mean
                                                                                  pain                              fatigue                            disability 
Lifetime diagnosis                      score    score               score                                No. 
1. Definite MD*, low dysphoria  34.51  45.6  0.66  49 
2. Subthreshold MD, low dysphoria  38.64 43.6 0.44 22 
3. No diagnosis, low dysphoria  39.64 39.9 0.52 76 
4. Definite MD, high dysphoria  62.22 68.3 1.18 18 
5. No diagnosis, high dysphoria  51.63 65.6 1.08 15 
P  0.003  0.000  0.000  —
Scheffe groups†  4 vs. 1  4 vs. 1 and 3;  4 vs. 1 and 3;  180 
 and 3  5 vs. 3  5 vs. 3  
* MD = major depression.     
† Comparisons show a significant difference between the means of each group at the 0.05 level. 
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from a large national sample of RA patients. We found 
the clearest evidence of a “scar” in the association be-
tween past episodes of major depression and current re-
ports of pain, However, we also found that, at least with 
respect to pain, the “scar” is only evident under current 
mood-priming conditions (20-21). 
Evidence of a “scar” that must be primed was re-
vealed when we compared the pain, fatigue, and dis-
ability reports of those with and those without a history 
of major depression. In the absence of current high lev-
els of dysphoria, RA patients who met the criteria for 
definite major depression at some time in their life but 
did not currently meet the criteria for even a subthresh-
old episode, did not report greater pain, disability, or 
fatigue than those without a depression history. How-
ever, when we compared the same history of depression 
groups in the context of their current reports of dys-
phoria (the priming condition), we found that patients 
with a history of depression and high levels of current 
dysphoria but no current definite major depression re-
ported the highest pain, fatigue, and disability of any 
patient group. Those with currently high levels of dys-
phoria, but without a history of depression, reported the 
next highest level on the 3 illness indicators. 
Although both groups reported relatively high levels 
of symptoms, the pain reports of patients with a history 
of depression offered the clearest indication of how past 
major depression operates to influence the future illness 
experience. The “scar” group, i.e., patients with a his-
tory of major depression and high levels of current dys-
phoria, reported more pain than those with low levels of 
current dysphoria irrespective of depression history. Al-
though patients without a depression history but with 
high levels of current dysphoria also reported high lev-
els of pain, the intensity of their pain was not different 
from that of any other group. Thus, the combination of 
past depression and current dysphoria created a risk 
factor for RA pain reports that exceeded the risk associ-
ated with high dysphoria alone. 
To our knowledge, this is the first study in a medi-
cal population to examine the “scar” hypothesis in re-
lation to medical symptoms, and we can only speculate 
as to the possible mechanisms that operate with respect 
to major depression and future symptom reports in RA. 
Others have postulated that the “scar” is a residua of the 
prior depression, a constellation of traits that remain sta-
ble between and within episodes, or a risk factor for re-
currence of depression (19). Our data suggest that in ad-
dition to being a risk factor for recurrence (27% of those 
with a past episode of depression reported a current epi-
sode as well), major depression leaves a residua, but that 
it operates primarily with respect to reports of pain. Our 
data also suggest that a history of depression alone is 
not sufficient to explain the high levels of pain reported 
in the “scar” group in this study. Thus, a history of de-
pression is not a stable trait that operates consistently, 
since many patients with a history of depression did not 
report higher levels of pain. Rather, the “scar” associ-
ated with a history of depression appears to be episodic 
and conditional on current symptoms of dysphoria. 
Most clinicians appreciate the relationship between 
current distress and their RA patients’ pain reports. Our 
data suggest that it is important to inquire beyond the 
current distress to the patient’s history of affective disor-
der. This assessment needs to include both the patient’s 
current complaints of distress and his or her history of 
affective disorder. New directions in cognitive-behav-
ioral therapy for primary care patients that focus on 
brief (one-to-three-session) interventions (31) and inter-
ventions designed for patients with a history of depres-
sion (32) should be considered for these high-risk pa-
tients with RA. Although the depression history itself 
cannot be influenced by such interventions, the prim-
ing factor (current dysphoria) should respond to the 
self- control strategies and cognitive-restructuring tech-
niques offered in these approaches. 
Although this study has revealed new and persua-
sive evidence of the long-term risk associated with a 
past episode of major depression, two rival explanations 
for our findings should be considered. First, it is possi-
ble that people with a past episode of depression sim-
ply experience higher levels of pain. This is unlikely, be-
cause our “scar” group reported levels of pain that were 
significantly higher than the group that shared their his-
tory of depression but not their high current dyspho-
ria. Alternatively, it is possible that what we describe as 
a “scar” is actually an example of mood (state)-depen-
dent recall (33), in which those with current dysphoria 
are more likely to overestimate their pain or more likely 
to recall past episodes of depression. It is unlikely that 
mood-dependent recall explains either possibility in this 
study, because the current dysphoria group without a 
history of depression did not report the same intensity 
of pain as our “scar” group. Similarly, our patients with 
current dysphoria were not more likely to recall a past 
episode of depression than were patients without cur-
rent dysphoria. However, future studies should inves-
tigate these possibilities and should examine the “scar” 
and priming hypotheses using a prospective study de-
sign with multiple, perhaps daily, reports of pain and 
mood, to avoid retrospective bias in symptom reports. 
Future studies should also take advantage of other 
diagnostic interviews that do not share the limitations 
of the DIS III-A. Our study was limited due to the prob-
lems inherent in obtaining unbiased reports of major de-
pression using such instruments as the DIS III-A, which 
relies on the participant’s attribution of organic versus 
nonorganic symptoms. Reliance on individual clinician 
judgment or on patient attribution increases the concept 
referred to by Spitzer et al. (34) as criterion variance, i.e., 
variations in formal inclusion and exclusion criteria used 
to reach diagnosis, which is a principal contributor to di-
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agnostic unreliability. Although we attempted to correct 
for this bias by having a psychiatrist review the problem 
cases, future studies that limit criterion variance by in-
cluding frequency and duration requirements, decision 
rules, and more specific probes on an item-by-item ba-
sis will bring us closer to understanding how an episode 
of depression might, years later, influence pain, fatigue, 
and functional limitations in patients with RA. 
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